Inhibitor of Apoptosis Proteins (IAP) are key regulators of cell survival. IAP antagonists are compounds designed to inhibit these proteins, unleashing apoptosis, a programmed cell death process, in cancer cells. By neutralizing IAP's anti-apoptotic effects, these antagonists offer a promising approach for cancer treatment, making malignant cells more susceptible to death and enhancing the effectiveness of other cancer therapies.